Israel Englander Catalent, Inc. Put Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 15, 2024	SELL	$42.56 - $59.82 $3.15 Million - $4.43 Million	-74,100 Reduced 64.94%	40,000 $2.26 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $3.67 Million - $5.31 Million	114,100 New	114,100 $5.13 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $4.89 Million - $8 Million	107,700 New	107,700 $7.08 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $723,600 - $1.13 Million	10,000 New	10,000 $724,000

513

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.